Nu Skin Enterprises (NYSE:NUS – Get Free Report) was upgraded by stock analysts at StockNews.com from a “hold” rating to a “buy” rating in a report released on Monday.
Nu Skin Enterprises Stock Performance
NYSE:NUS opened at $7.44 on Monday. The firm has a market cap of $369.94 million, a P/E ratio of -2.52 and a beta of 0.92. The company has a current ratio of 1.82, a quick ratio of 1.17 and a debt-to-equity ratio of 0.56. The stock’s 50 day simple moving average is $6.71 and its 200-day simple moving average is $6.95. Nu Skin Enterprises has a 12-month low of $5.32 and a 12-month high of $14.00.
Nu Skin Enterprises (NYSE:NUS – Get Free Report) last posted its quarterly earnings results on Thursday, May 8th. The company reported $0.23 earnings per share for the quarter, beating analysts’ consensus estimates of $0.15 by $0.08. Nu Skin Enterprises had a positive return on equity of 5.86% and a negative net margin of 8.46%. The firm had revenue of $364.49 million for the quarter, compared to the consensus estimate of $352.06 million. Equities analysts anticipate that Nu Skin Enterprises will post 1.05 EPS for the current year.
Institutional Trading of Nu Skin Enterprises
Nu Skin Enterprises Company Profile
Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.
Recommended Stories
- Five stocks we like better than Nu Skin Enterprises
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- NVIDIA Stock Surges on Bullish News: How High Could It Climb?
- When to Sell a Stock for Profit or Loss
- Why Boeing May Be Ready to Take Off After Latest Developments
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- eBay Nears Big Breakout: Time to Buy the Under-the-Radar Winner?
Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.